Go to deals
Healthcare

Bluebird Care has been acquired by Interim Healthcare Inc.

US-based care-at-home franchisor Interim Healthcare Inc. has acquired Bluebird Care, based in the UK, a national provider of care in the home. Financial details have not been provided.

Bluebird Care offers a unique service of tailored care visits from 30 minutes to full live-in support. The company has nearly 200 offices in the UK and the Republic of Ireland.

Founded in 1966, Interim Healthcare has more than 300 independently owned and operated franchise locations providing a variety of home health, senior care, hospice, palliative care, pediatric care and healthcare staffing services.

UK-based Oaklins Smith & Williamson, assisted by the team in Los Angeles, advised the seller in this transaction.

Parties

Talk to the deal team

Stuart Goodman

Partner
London, United Kingdom
Oaklins S&W

Gary Rabishaw

Managing Director
Los Angeles, United States
Oaklins Intrepid

Related deals

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Healthcare

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval

Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.

Learn more
Rare Patient Voice has been acquired by Konovo
Healthcare | TMT

Rare Patient Voice has been acquired by Konovo

Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.

Learn more
Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
Healthcare

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.

Learn more